0	1	{'start':(0, 0), 'end':(0, 19), 'text':'The docking protein Gab1 is the primary mediator of EGF stimulated activation of the PI-3K / Akt cell survival pathway'}
12	40	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Background'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 48), 'text':'Ligand stimulation of the epidermal growth factor receptor ( EGFR ) and the three other members of the EGFR family of receptor tyrosine kinases ( ErbB2 , ErbB3 and ErbB4 ) results in tyrosine autophosphorylation , recruitment of signaling proteins , and activation of distinct complement of signaling pathways'}, {'start':(1, 49), 'end':(1, 57), 'text':'that regulate a great variety of cellular responses .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 4), 'text':'One of the signaling pathways'}, {'start':(2, 5), 'end':(2, 18), 'text':'that is activated by the EGFR is the phosphatidylinositol-3 kinase ( PI-3 kinase )'}]}, {'start':(2, 19), 'end':(2, 26), 'text':'/ Akt anti-apoptic signaling pathway [ ] .'}]}]}]}, {'start':(3, 0), 'end':(3, 17), 'text':'The PI-3 kinase holoenzyme consists of a regulatory subunit ( p85 ) and a catalytic p110 subunit .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 6), 'text':'The regulatory subunit contains two SH2 domains'}, {'start':(4, 7), 'end':(4, 19), 'text':'that bind specifically to pYXXM motifs in a variety of cellular proteins ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 20), 'end':(4, 33), 'text':'including receptor tyrosine kinases such as the PDGF ( platelet derived growth factor )'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 34), 'end':(4, 35), 'text':'receptor ,'}, {'start':(4, 36), 'end':(4, 54), 'text':'and c-kit and docking proteins such as IRS ( insulin receptor substrate ) 1 , IRS2 and Gab1 .'}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 15), 'text':'Although the cytoplasmic domain of the EGFR does not contain any canonical p85 binding motifs ,'}, {'start':(5, 16), 'end':(5, 27), 'text':'EGF stimulation leads to PI-3 kinase activation by an indirect mechanism .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 3), 'text':'It has been proposed'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(6, 4), 'end':(6, 14), 'text':'that the PI-3 kinase is activated in response to EGF stimulation'}, {'start':(6, 15), 'end':(6, 27), 'text':'as a consequence of formation of EGFR and ErbB3 heterodimers [ ] .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 14), 'text':'Unlike EGFR , the cytoplasmic region of ErbB3 contains at least six pYXXM motifs .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 13), 'text':'Indeed , EGF stimulation of cells co-expressing the EGFR and ErbB3 results in recruitment'}, {'start':(8, 14), 'end':(8, 25), 'text':'and activation of PI-3 kinase by tyrosine phosphorylated ErbB3 [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 13), 'text':'EGF stimulation of PI-3 kinase may also be mediated by the docking protein Gab1'}, {'start':(9, 14), 'end':(9, 19), 'text':'( Grb2 associated binder-1 ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 25), 'text':'EGF stimulation leads to tyrosine phosphorylation of Gab1 enabling recruitment and activation of PI-3 kinase by the three canonical pYXXM motifs on Gab1 [ ] .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 9), 'text':'Gab1 was originally identified as a Grb2 binding protein ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 10), 'end':(11, 15), 'text':'and was shown to be tyrosine'}, {'start':(11, 16), 'end':(11, 30), 'text':'phosphorylated in response to treatment with a variety of growth factors [ - ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 6), 'text':'Gab1 contains a number of tyrosine residues'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 7), 'end':(12, 17), 'text':'that could serve as potential binding sites for the SH2 domain'}, {'start':(12, 18), 'end':(12, 33), 'text':'containing proteins Grb2 , PI-3 kinase , and the protein tyrosine phosphatase Shp2 [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 4), 'text':'While there have been reports'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 5), 'end':(13, 16), 'text':'that Gab1 binds directly to the EGFR via an 83-amino acid stretch'}, {'start':(13, 17), 'end':(13, 24), 'text':'termed the Met-binding-domain or MBD [ ] ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 25), 'end':(13, 43), 'text':'the majority of Gab1 is believed to be indirectly associated with the EGFR via the adaptor protein Grb2 ,'}, {'start':(13, 44), 'end':(13, 61), 'text':'which binds to a proline rich region on Gab1 via its C-terminal SH3 domain [ - ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 5), 'text':'Cells over-expressing a mutant Gab1 protein'}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 6), 'end':(14, 28), 'text':'containing tyrosine to phenylalanine mutations at the three p85 binding sites have been shown to be defective in EGF induced JNK activation ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 29), 'end':(14, 50), 'text':'and treatment of cells over-expressing wild type Gab1 with PI-3 kinase inhibitors interferes with MAPK signaling in response to EGF treatment ,'}, {'start':(14, 51), 'end':(14, 65), 'text':'thus revealing a link between Gab1 and PI-3 kinase in EGF induced mitogenic signaling .'}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 22), 'text':'Furthermore , the PI-3 kinase product phosphatidylinositol ( 3,4,5 ) triphosphate ( PIP3 ) has been shown to bind to the pleckstrin homology'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 23), 'end':(15, 28), 'text':'( PH ) domain of Gab1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 29), 'end':(15, 35), 'text':'resulting in membrane association of Gab1 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 36), 'end':(15, 40), 'text':'suggesting a positive feedback loop'}, {'start':(15, 41), 'end':(15, 63), 'text':'in which PI-3 kinase acts as both an upstream regulator and a downstream effector of Gab1 signaling via the EGFR [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 6), 'text':'Gab1 thus acts as a docking protein'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 7), 'end':(16, 15), 'text':'facilitating the recruitment of a multi protein signaling complex'}, {'start':(16, 16), 'end':(16, 28), 'text':'including the EGFR , p85 and Shp2 in response to EGF treatment .'}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(17, 0), 'end':(17, 19), 'text':'Although the role of the Shp2 protein in the control of EGFR and Gab1 interactions is not well understood ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 20), 'end':(17, 23), 'text':'several studies have suggested'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 24), 'end':(17, 30), 'text':'that Gab1 associated Shp2 may influence EGF'}, {'start':(17, 31), 'end':(17, 35), 'text':'induced PI-3 kinase signaling .'}]}]}]}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 0), 'end':(18, 3), 'text':'Previous work has shown'}, {'start':(18, 4), 'end':(18, 13), 'text':'that Gab1 is not a global substrate of Shp2 ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 14), 'end':(18, 26), 'text':'as complex formation between Gab1 and Shp2 does not reduce the total EGF'}, {'start':(18, 27), 'end':(18, 35), 'text':'induced tyrosine phosphorylation levels of Gab1 [ ] .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 5), 'text':'However there have been several reports'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 6), 'end':(19, 6), 'text':'suggesting'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 7), 'end':(19, 17), 'text':'that Shp2 may specifically de-phosphorylate the tyrosine phosphorylation sites on Gab1'}, {'start':(19, 18), 'end':(19, 22), 'text':'that bind to p85 ,'}]}, {'start':(19, 23), 'end':(19, 41), 'text':'thus terminating recruitment of PI-3 kinase and EGF induced activation of the PI-3 kinase pathway [ - ] .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 0), 'end':(20, 3), 'text':'It has been shown'}, {'start':(20, 4), 'end':(20, 34), 'text':'that cells devoid of Shp2 show an increase in PI-3 kinase activity , as well as elevated and sustained levels of Akt activation in response to EGF treatment [ ] .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(21, 0), 'end':(21, 2), 'text':'It was reported'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 3), 'end':(21, 18), 'text':'that treatment of cells with PI-3 kinase inhibitors or with the phosphatidylinositol ( 3,4,5 ) triphosphate'}, {'start':(21, 19), 'end':(21, 37), 'text':'( PIP3 ) phosphatase PTEN interferes with the association between Gab1 and Shp2 in response to EGF treatment ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 38), 'end':(21, 48), 'text':'suggesting PI-3 kinase may be required for Shp2 recruitment of Gab1'}, {'start':(21, 49), 'end':(21, 54), 'text':'following EGF stimulation [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 10), 'text':'However , the mechanism for this postulated recruitment is unknown .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 2), 'text':'In the experiments'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 3), 'end':(23, 7), 'text':'presented here we utilized fibroblasts'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(23, 8), 'end':(23, 13), 'text':'isolated from Gab1- and- mouse embryos'}, {'start':(23, 14), 'end':(23, 35), 'text':'in order to examine the role of Gab1 in EGF mediated activation of the PI-3 kinase and Akt cell survival pathway .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 4), 'text':'We also address the question'}, {'start':(24, 5), 'end':(24, 19), 'text':'of whether ErbB3 recruitment of PI-3 kinase is dependent on or independent of Gab1 .'}]}]}, {'start':(25, 0), 'end':(25, 20), 'text':'Our results demonstrate a clear requirement for Gab1 in recruitment and activation of PI-3 kinase in response to EGF stimulation .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 3), 'text':'Additionally , we show'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(26, 4), 'end':(26, 4), 'text':'that'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(26, 5), 'end':(26, 14), 'text':'while Shp2 does not mediate global dephosphorylation of Gab1 ,'}, {'start':(26, 15), 'end':(26, 32), 'text':'it does appear to negatively regulate the EGF induced activation of PI-3 kinase through an undefined mechanism .'}]}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(27, 0), 'end':(27, 2), 'text':'Finally we demonstrate'}, {'start':(27, 3), 'end':(27, 33), 'text':'that ErbB3 is capable of recruiting PI-3 kinase in the absence of Gab1 , but Gab1 functions as the major mediator of PI-3 kinase activation in response to EGF stimulation .'}]}]}
193	194	{'start':(0, 0), 'end':(0, 2), 'text':'Figures and Tables'}
1	12	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Background'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 4), 'text':'Gab1 is a docking protein'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 5), 'end':(1, 26), 'text':'that recruits phosphatidylinositol-3 kinase ( PI-3 kinase ) and other effector proteins in response to the activation of many receptor tyrosine kinases'}, {'start':(1, 27), 'end':(1, 30), 'text':'( RTKs ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(2, 0), 'end':(2, 17), 'text':'As the autophosphorylation sites on EGF-receptor ( EGFR ) do not include canonical PI-3 kinase binding sites ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 18), 'end':(2, 20), 'text':'it is thought'}, {'start':(2, 21), 'end':(2, 38), 'text':'that EGF stimulation of PI-3 kinase and its downstream effector Akt is mediated by an indirect mechanism .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 0), 'text':'Results'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 2), 'text':'We used fibroblasts'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(4, 3), 'end':(4, 8), 'text':'isolated from Gab1- and- mouse embryos'}, {'start':(4, 9), 'end':(4, 26), 'text':'to explore the mechanism of EGF stimulation of the PI-3 kinase and Akt anti-apoptotic cell signaling pathway .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 1), 'text':'We demonstrate'}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 2), 'end':(5, 16), 'text':'that Gab1 is essential for EGF stimulation of PI-3 kinase and Akt in these cells'}, {'start':(5, 17), 'end':(5, 44), 'text':'and that these responses are mediated by complex formation between p85 , the regulatory subunit of PI-3 kinase , and three canonical tyrosine phosphorylation sites on Gab1 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 20), 'text':'Furthermore , complex formation between Gab1 and the protein tyrosine phosphatase Shp2 negatively regulates Gab1 mediated PI-3 kinase and Akt activation'}, {'start':(6, 21), 'end':(6, 24), 'text':'following EGF-receptor stimulation .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(7, 0), 'end':(7, 2), 'text':'We also demonstrate'}, {'start':(7, 3), 'end':(7, 23), 'text':'that tyrosine phosphorylation of ErbB3 may lead to recruitment and activation of PI-3 kinase and Akt in Gab1- and- MEFs .'}]}]}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(8, 0), 'end':(8, 0), 'text':'Conclusions'}, {'start':(9, 0), 'end':(9, 21), 'text':'The primary mechanism of EGF induced stimulation of the PI-3 kinase and Akt anti-apoptotic pathway occurs via the docking protein Gab1 .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(10, 0), 'end':(10, 6), 'text':'However , in cells expressing ErbB3 ,'}, {'start':(10, 7), 'end':(10, 25), 'text':'EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1 dependent or Gab1 independent manner .'}]}]}]}
146	187	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Methods'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 1), 'text':'Expression constructs'}, {'start':(2, 0), 'end':(2, 17), 'text':'Expression vectors for wild type Gab1 and for Gab1Deltap85 ( Y446F/Y472F/Y589F ) were previously described [ ] .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 26), 'text':'The cDNAs of Gab1 ( pcDNA3-Gab1-WT ) , Gab1 F446/472/589 ( pcDNA3-Gab1-3YF ) , and ErbB3 ( pcDNA3-ErbB3 ) were subcloned into the mammalian retroviral vector pBabe'}, {'start':(3, 27), 'end':(3, 33), 'text':'containing a gene for puromycin resistance .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 46), 'text':'The Gab1 F627 and 659 and Gab1 F446/472/589 / 627 and 659 mutants were generated by site directed mutagenesis ( Strategene ) carried out on pBabe-Gab1-WT ( to generate Gab1 F627 and 659 ) or pBabe-Gab1 F446/472/589 ( to generate Gab1 F446/472/589 / 627 and 659 )'}, {'start':(4, 47), 'end':(4, 53), 'text':'according to the manufacturers \' specifications .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 3), 'text':'Cell lines and culture'}, {'start':(6, 0), 'end':(6, 20), 'text':'Gab1 deficient ( Gab1 -/ - ) mouse embryonic fibroblasts ( MEFs ) were obtained from Walter Birchmeier [ ] .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 9), 'text':'Wild type or Gab1- and- MEFs were maintained in DMEM'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 10), 'end':(7, 16), 'text':'supplemented with 10 % fetal bovine serum'}, {'start':(7, 17), 'end':(7, 36), 'text':'( Gibco ) , 2 mM L-glutamine ( Gibco ) , and 100 mug each of penicillin and streptomycin .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 2), 'text':'The retroviral vectors'}, {'start':(8, 3), 'end':(8, 27), 'text':'described above ( pBabe , pBabe-Gab1 , pBabe-Gab1-Gab1 F446/472/589 , pBabe-Gab1-Gab1 F627 and 659 , pBabe-Gab1-Gab1 F446/472/589 / 627 and 659 , and pBabe-ErbB3 )'}]}, {'start':(8, 28), 'end':(8, 29), 'text':'were used'}]}, {'start':(8, 30), 'end':(8, 38), 'text':'to transfect the amphitropic retroviral packaging cell line GPG'}]}, {'start':(8, 39), 'end':(8, 44), 'text':'( obtained from Joan Brugge )'}]}, {'start':(8, 45), 'end':(8, 57), 'text':'and high-titer viral stocks were used to infect Gab1 -/ - MEFs .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 4), 'text':'Cells were selected in medium'}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 5), 'end':(9, 7), 'text':'supplemented with puromycin'}, {'start':(9, 8), 'end':(9, 18), 'text':'and pools of selected cells were used for further experiments .'}]}]}]}, {'start':(10, 0), 'end':(10, 12), 'text':'Prior to stimulation with EGF , cells were starved in serum-free medium .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 2), 'text':'Immunoprecipitation and immunoblotting'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 5), 'text':'Cells were grown on 15-cm plates'}, {'label':'joint', 'direction':'None', 'children':[{'start':(12, 6), 'end':(12, 13), 'text':'as described above to approximately 80 % confluence'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 14), 'end':(12, 19), 'text':'and then starved overnight in DMEM'}, {'start':(12, 20), 'end':(12, 22), 'text':'without serum .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 3), 'text':'Cells were left unstimulated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 4), 'end':(13, 10), 'text':'or were stimulated with recombinant human EGF'}, {'start':(13, 11), 'end':(13, 16), 'text':'( Invitrogen ) as indicated .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 9), 'text':'Stimulations were halted by the addition of ice-cold PBS .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 4), 'text':'Cells were washed in PBS'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 5), 'end':(15, 8), 'text':'and lysed in buffer'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 9), 'end':(15, 13), 'text':'containing 1 % Triton X-100'}, {'start':(15, 14), 'end':(15, 19), 'text':'as previously described [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 8), 'text':'For Gab1 immunoprecipitations , a mixture of polyclonal antibodies'}, {'start':(16, 9), 'end':(16, 17), 'text':'directed against both the N- and C-termini of Gab1'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 18), 'end':(16, 24), 'text':'and cross linked to Protein A Sepharose'}, {'start':(16, 25), 'end':(16, 38), 'text':'( Zymed ) was incubated with cell extracts for 2-4 hours at 4degreesC .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 8), 'text':'For p85 immunoprecipitations , a mixture of polyclonal antibodies'}, {'start':(17, 9), 'end':(17, 35), 'text':'directed against the N-terminal SH2 domain of p85 and the full-length p85 protein ( Upstate ) was incubated with cell extracts for 2-4 hours at 4degreesC .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 6), 'text':'For EGFR immunoprecipitations , a polyclonal antibody'}, {'start':(18, 7), 'end':(18, 22), 'text':'directed against the C-terminus of the EGFR was incubated with cell extracts overnight at 4degreesC .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 8), 'text':'For ErbB3 immunoprecipitations , a mixture of polyclonal antibodies'}, {'start':(19, 9), 'end':(19, 26), 'text':'directed against both the N- and C-termini of ErbB3 was incubated with cell extracts overnight at 4degreesC .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 6), 'text':'Protein A Sepharose was added to immunoprecipitates'}, {'start':(20, 7), 'end':(20, 10), 'text':'( except anti-Gab1 )'}]}, {'start':(20, 11), 'end':(20, 18), 'text':'and incubated for 1 hour at 4degreesC .'}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 5), 'text':'Immunoprecipitates were then washed in buffer'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 6), 'end':(21, 11), 'text':'containing 0.1 % Triton X-100 ,'}, {'start':(21, 12), 'end':(21, 17), 'text':'separated by SDS and PAGE ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 18), 'end':(21, 22), 'text':'and transferred to nitrocellulose membranes'}, {'start':(21, 23), 'end':(21, 26), 'text':'( Bio-Rad ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(22, 0), 'end':(22, 13), 'text':'For Akt immunoblotting , total cell extracts were separated directly by SDS and PAGE'}, {'start':(22, 14), 'end':(22, 19), 'text':'and transferred to nitrocellulose membranes .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(23, 0), 'end':(23, 13), 'text':'Membranes were blocked for 1 hour or overnight in 5 % BSA and TBS'}, {'start':(23, 14), 'end':(23, 18), 'text':'and immunoblotted as indicated .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 12), 'text':'The anti-phosphotyrosine blotting was carried out with antibody 4G10 ( Upstate ) .'}, {'start':(25, 0), 'end':(25, 16), 'text':'Anti-Gab1 , anti-EGFR and anti-ErbB3 blotting was performed with the indicated polyclonal antibodies ( Upstate ) .'}]}, {'start':(26, 0), 'end':(26, 12), 'text':'Anti-Shp2 blotting was carried out with polyclonal antibody ( Santa Cruz ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 10), 'text':'Anti-phosphoSer473-Akt and anti-Akt blotting were performed with the respective polyclonal antibodies'}, {'start':(27, 11), 'end':(27, 16), 'text':'( Cell Signaling Technology ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 11), 'text':'Proteins were visualized by incubation with Enhanced Chemiluminescence ( Amersham Pharmacia )'}, {'start':(28, 12), 'end':(28, 18), 'text':'according to the manufacturer \'s specifications .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 2), 'text':'PI-3 kinase assay'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 6), 'text':'The PI-3 kinase assay was performed essentially'}, {'start':(30, 7), 'end':(30, 13), 'text':'as previously described [ - ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 4), 'text':'Briefly , cells were serum'}, {'label':'joint', 'direction':'None', 'children':[{'start':(31, 5), 'end':(31, 8), 'text':'starved for 24 hours'}, {'label':'joint', 'direction':'None', 'children':[{'start':(31, 9), 'end':(31, 15), 'text':'and stimulated with EGF as indicated ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(31, 16), 'end':(31, 20), 'text':'and cell extracts were prepared'}, {'start':(31, 21), 'end':(31, 24), 'text':'as described above .'}]}]}]}]}]}, {'start':(32, 0), 'end':(32, 23), 'text':'The lysates were immunoprecipitated using anti-Gab1 polyclonal antibodies or the monoclonal anti-phosphotyrosine antibody PY20 ( Santa Cruz ) for 2 hours at 4degreesC .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 12), 'text':'Protein A Sepharose was incubated with immunoprecipitates for 1 hour at 4degreesC .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(34, 0), 'end':(34, 54), 'text':'The immunoprecipitates were washed three times with Buffer 1 ( 1X PBS , 1 % NP-40 ) , twice with Buffer 2 ( 0.5 M LiCl , 0.1 M Tris pH 7.5 ) , twice with TNE ( 10 mM Tris pH 7.5 , 100 mM NaCl , 1 mM EDTA pH 8.0 ) ,'}, {'start':(34, 55), 'end':(34, 89), 'text':'and twice with Buffer 4 ( 20 mM Hepes pH 7.5 , 50 mM NaCl , 5 mM EDTA pH 8.0 , 0.03 % NP-40 , 30 mM Tatrasodium Pyrophosphate ( Sigma ) ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(35, 0), 'end':(35, 24), 'text':'L-alpha-Phosphatidylinositol ( Sigma ) was added ( 10 mul of a sonicated solution at 10 mg and ml in 20 mM HEPES pH 7.5 )'}, {'start':(35, 25), 'end':(35, 74), 'text':'and the reaction was initiated by the addition of 50 mul of the kinase buffer ( 20 mM Tris pH 7.5 , 75 mM NaCl , 10 mM MgCl 2 10 muM ATP , 100 mM adenosine , 10 muCi [ gamma- 32 P ] ATP ) per sample .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(36, 0), 'end':(36, 8), 'text':'Samples were incubated at 30degreesC for 15 minutes ,'}, {'start':(36, 9), 'end':(36, 21), 'text':'and the reaction was stopped by addition of 100 mul 1N HCl .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(37, 0), 'end':(37, 17), 'text':'Samples were extracted by addition of 200 mul CHCl 3 / CH 3 OH ( 1:1 ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(38, 0), 'end':(38, 3), 'text':'The samples were vortexed'}, {'label':'joint', 'direction':'None', 'children':[{'start':(38, 4), 'end':(38, 6), 'text':'and centrifuged ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 7), 'end':(38, 11), 'text':'and the lower organic phases'}, {'start':(38, 12), 'end':(38, 21), 'text':'containing phospholipids were dried at 27degreesC for two hours .'}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(39, 0), 'end':(39, 32), 'text':'Samples were resuspended in 10 mul of PI-4-P standard ( 0.5 ml CHCl 3 , 0.5 ml CH 3 OH , 2.5 mul HCl , 1 mg L-alpha-Phosphatidylinositol 4-monophosphate ( Sigma ) )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 33), 'end':(39, 38), 'text':'and subjected to thin layer chromatography'}, {'start':(39, 39), 'end':(39, 63), 'text':'( TLC plates - VWR ) in CHCl 3 / CH 3 OH and NH 4 OH and H 2 O ( 45:35:7:3 ) .'}]}]}]}, {'start':(40, 0), 'end':(40, 12), 'text':'The TLC plates were exposed in a PhosphorImager cassette for four days .'}]}]}]}
138	146	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Conclusions'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 1), 'text':'The results'}, {'start':(1, 2), 'end':(1, 4), 'text':'presented here demonstrate'}]}, {'start':(1, 5), 'end':(1, 22), 'text':'an absolute requirement for Gab1 in EGF induced activation of the PI-3 kinase and Akt signaling pathway .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(2, 0), 'end':(2, 2), 'text':'Using this approach'}, {'start':(2, 3), 'end':(2, 20), 'text':'we demonstrated a strict requirement for association between Gab1 and p85 in EGF induced PI-3 kinase activation ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 21), 'end':(2, 21), 'text':'suggesting'}, {'start':(2, 22), 'end':(2, 35), 'text':'that Gab1 indeed provides an essential link between the EGFR and PI-3 kinase .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 18), 'text':'Additionally , p85 binding does not play a significant role in Shp2 recruitment to the EGFR-Gab1 signaling complex ,'}, {'start':(3, 19), 'end':(3, 26), 'text':'in contrast to previous studies [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 0), 'end':(4, 2), 'text':'We further demonstrated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 3), 'end':(4, 29), 'text':'that the Gab1 and Shp2 complex is responsible for the negative regulation of the strength and duration of PI-3 kinase and Akt signaling in response to EGF'}, {'start':(4, 30), 'end':(4, 37), 'text':'previously observed in Shp2 -/ - cells .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 10), 'text':'ErbB3 expression can bypass the requirement for Gab1 in EGFR signaling'}, {'start':(5, 11), 'end':(5, 27), 'text':'and can partially rescue EGF induced activation of the PI-3 kinase and Akt cell survival pathway .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 12), 'text':'This alternate pathway to PI-3 kinase activation may provide cells with a means'}, {'start':(6, 13), 'end':(6, 31), 'text':'of controlling either the strength or duration of PI-3 kinase signaling through differential expression of Gab1 and ErbB3 ,'}]}, {'start':(6, 32), 'end':(6, 41), 'text':'since the ErbB3 mediated response appears to be weaker .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 5), 'text':'Thus Gab1 plays an essential role'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 6), 'end':(7, 17), 'text':'in bringing together a multi protein signaling complex in response to EGF'}, {'start':(7, 18), 'end':(7, 26), 'text':'that modulates a critical aspect of cellular survival .'}]}]}]}]}
40	138	{'label':'evaluation', 'direction':'LeftToRight', 'children':[{'label':'topic-change', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Results and Discussion'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 3), 'text':'Previous studies have suggested'}, {'start':(1, 4), 'end':(1, 17), 'text':'that ErbB3 and Gab1 can function as links between EGFR and PI-3 kinase .'}]}]}, {'label':'topic-change', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 5), 'text':'In this report we use MEFs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 6), 'end':(2, 13), 'text':'derived from Gab1 -/ - embryos [ ]'}, {'start':(2, 14), 'end':(2, 33), 'text':'to explore the contribution of Gab1 and ErbB3 to EGF stimulation of PI-3 kinase and Akt in these cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 10), 'text':'Gab1 is essential for EGF stimulation of PI-3 kinase and Akt'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 0), 'text':'MEFs'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 1), 'end':(4, 15), 'text':'derived from Gab1- and- or wild type ( WT ) embryos were stimulated with EGF'}, {'start':(4, 16), 'end':(4, 32), 'text':'and assayed for Gab1 tyrosine phosphorylation , for activation of PI-3 kinase and for Akt stimulation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 4), 'text':'As shown in Figure ,'}, {'start':(5, 5), 'end':(5, 20), 'text':'the endogenous Gab1 present in WT MEFs is tyrosine phosphorylated in response to EGF treatment .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 4), 'text':'As shown in Figure ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 5), 'end':(6, 21), 'text':'Gab1 -/ - MEFs displayed very low levels of EGF induced PI-3 kinase activity relative to cells'}, {'start':(6, 22), 'end':(6, 24), 'text':'expressing Gab1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 19), 'text':'We did observe an approximate 2-fold increase in this low-level basal PI-3 kinase activity in Gab1 -/ - MEFs ,'}, {'start':(7, 20), 'end':(7, 27), 'text':'which represents a Gab1 independent signaling pathway .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 21), 'text':'Gab1 -/ - and WT MEFs were additionally stimulated with EGF and the activation of Akt was analyzed by immunoblotting with antibodies'}, {'start':(8, 22), 'end':(8, 30), 'text':'which recognize specifically the activated form of Akt .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(9, 0), 'end':(9, 10), 'text':'As shown in Figure ( top and middle panels ) ,'}, {'label':'temporal', 'direction':'None', 'children':[{'start':(9, 11), 'end':(9, 24), 'text':'Gab1 -/ - cells display no activation of Akt in response to EGF ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(9, 25), 'end':(9, 28), 'text':'while WT MEFs show'}, {'start':(9, 29), 'end':(9, 39), 'text':'EGF stimulated Akt activation within two minutes of EGF treatment .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 1), 'text':'The cDNA'}, {'start':(10, 2), 'end':(10, 15), 'text':'encoding the wild type murine Gab1 sequence was cloned into a retroviral vector ,'}]}, {'start':(10, 16), 'end':(10, 27), 'text':'and the virus was used to infect Gab1 -/ - MEFs .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 11), 'text':'Stable cell lines were selected for co-transduction of a puromycin resistance gene'}, {'start':(11, 12), 'end':(11, 22), 'text':'and pools of selected cells were used for further analysis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 4), 'text':'As shown in Figure ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 5), 'end':(12, 25), 'text':'the ectopic Gab1 protein was expressed at slightly lower levels in the Gab1 -/ - MEFs relative to endogenous Gab1 expression'}, {'start':(12, 26), 'end':(12, 32), 'text':'seen in the wild type MEFs .'}]}]}, {'start':(13, 0), 'end':(13, 23), 'text':'Quantitation by densitometry reveals Gab1 expression in wild type MEFs to be 1.4-fold higher than ectopic Gab1 expression in Gab1 -/ - MEFs .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 10), 'text':'Treatment with EGF induced tyrosine phosphorylation of the exogenous Gab1 protein'}, {'start':(14, 11), 'end':(14, 28), 'text':'expressed in the Gab1 -/ - MEFs at levels similar to endogenous Gab1 in wild type MEFs .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(15, 0), 'end':(15, 4), 'text':'As shown in Figure ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 5), 'end':(15, 17), 'text':'expression of exogenous Gab1 in the Gab1 -/ - MEFs results in Gab1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 18), 'end':(15, 21), 'text':'associated PI-3 kinase activity'}, {'start':(15, 22), 'end':(15, 28), 'text':'that is augmented following EGF treatment .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 8), 'text':'The low level of EGF induced PI-3 kinase activity'}, {'start':(16, 9), 'end':(16, 14), 'text':'observed in the Gab1 -/ -'}]}, {'start':(16, 15), 'end':(16, 28), 'text':'cells may be due to signaling via an alternate , Gab1 independent mechanism .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(17, 0), 'end':(17, 11), 'text':'These cells were additionally treated with EGF over a period of time'}, {'start':(17, 12), 'end':(17, 31), 'text':'and the activation of Akt was assayed by immunoblotting with antibodies specific for the Ser473 phosphorylated form of Akt .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 1), 'text':'The experiment'}, {'start':(18, 2), 'end':(18, 5), 'text':'presented in Fig shows'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 6), 'end':(18, 16), 'text':'that ectopic expression of Gab1 in the Gab1 deficient cells rescues'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 17), 'end':(18, 25), 'text':'EGF induced Akt activation to levels similar to those'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 26), 'end':(18, 28), 'text':'observed in EGF'}, {'start':(18, 29), 'end':(18, 33), 'text':'treated wild type MEFs .'}]}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 2), 'text':'Taken together ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 3), 'end':(19, 5), 'text':'these results demonstrate'}, {'start':(19, 6), 'end':(19, 18), 'text':'that Gab1 is required for EGF stimulation of PI-3 kinase and Akt .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 19), 'text':'The canonical p85 binding sites on Gab1 are essential for PI-3 kinase and Akt activation in response to EGF stimulation'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 1), 'text':'The cDNA'}, {'start':(21, 2), 'end':(21, 7), 'text':'encoding a mutant Gab1 protein ,'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(21, 8), 'end':(21, 34), 'text':'containing tyrosine to phenylalanine point mutations at the three binding sites for the p85 regulatory subunit of PI-3 kinase ( Y446F/Y472F/Y589F ) ( Gab1 F446/472/589 ) ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(21, 35), 'end':(21, 40), 'text':'was cloned into a retroviral vector'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(21, 41), 'end':(21, 50), 'text':'and used to generate pools of stable MEF cell lines'}, {'start':(21, 51), 'end':(21, 54), 'text':'as described above .'}]}]}]}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 18), 'text':'We first assayed the cells for Gab1 expression , and for the ability of the mutant Gab1 F446/472/589 protein'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 19), 'end':(22, 21), 'text':'to become tyrosine'}, {'start':(22, 22), 'end':(22, 28), 'text':'phosphorylated in response to EGF treatment .'}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(23, 0), 'end':(23, 4), 'text':'As shown in Figure ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 5), 'end':(23, 19), 'text':'both wild type Gab1 and Gab1 F446/472/589 undergo tyrosine phosphorylation in response to EGF treatment'}, {'start':(23, 20), 'end':(23, 25), 'text':'( upper left panel ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(24, 0), 'end':(24, 7), 'text':'Quantitation of multiple experiments by densitometry reproducibly demonstrates'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(24, 8), 'end':(24, 19), 'text':'that Gab1 F446/472/589 is tyrosine phosphorylated following EGF treatment to similar levels'}, {'start':(24, 20), 'end':(24, 26), 'text':'when normalized for Gab1 expression levels .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 7), 'text':'We next subjected lysates from unstimulated or EGF'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 8), 'end':(25, 14), 'text':'stimulated cells to immunoprecipitation with anti-Gab1 antibodies'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(25, 15), 'end':(25, 15), 'text':'followed'}, {'start':(25, 16), 'end':(25, 21), 'text':'by immunoblotting with anti-p85 antibodies .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 7), 'text':'As has been demonstrated previously [ ] ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 8), 'end':(26, 13), 'text':'wild type Gab1 readily coimmunoprecipitated p85'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 14), 'end':(26, 17), 'text':'following EGF treatment ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(26, 18), 'end':(26, 24), 'text':'while the Gab1 F446/472/589 mutant protein failed'}, {'start':(26, 25), 'end':(26, 31), 'text':'to show an association with p85 ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 32), 'end':(26, 32), 'text':'confirming'}, {'start':(26, 33), 'end':(26, 43), 'text':'that the Gab1 F446/472/589 protein is deficient in p85 binding .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 9), 'text':'Similar levels of Gab1 expression in these cells were confirmed'}, {'start':(27, 10), 'end':(27, 19), 'text':'by reprobing the Gab1 phosphotyrosine blot with anti-Gab1 antibodies .'}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 10), 'text':'Additionally , total cell lysates of all Gab1 expressing cell lines'}, {'start':(28, 11), 'end':(28, 20), 'text':'described in this study were subjected to anti-Gab1 immunoblotting ,'}]}, {'start':(28, 21), 'end':(28, 34), 'text':'providing independent evidence for similar levels of Gab1 expression across all cell lines .'}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(29, 0), 'end':(29, 11), 'text':'Because the substrates of Shp2 are for the most part unknown ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 12), 'end':(29, 23), 'text':'we were additionally interested in examining the state of EGFR tyrosine phosphorylation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 24), 'end':(29, 27), 'text':'following treatment with EGF'}, {'label':'condition', 'direction':'LeftToRight', 'children':[{'start':(29, 28), 'end':(29, 31), 'text':'in order to determine'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 32), 'end':(29, 36), 'text':'if the failure of Gab1'}, {'start':(29, 37), 'end':(29, 40), 'text':'to bind p85 ,'}]}, {'start':(29, 41), 'end':(29, 45), 'text':'and potentially recruit Shp2 ,'}]}, {'start':(29, 46), 'end':(29, 52), 'text':'would influence levels of EGFR autophosphorylation .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 21), 'text':'However , stimulation with EGF for varying time intervals revealed no significant differences in the levels of autophosphorylation of EGFR in cells'}, {'start':(30, 22), 'end':(30, 31), 'text':'expressing wild type Gab1 versus the Gab1 F446/472/589 mutant .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 9), 'text':'A linear representation of the EGF induced EGFR tyrosine phosphorylation'}, {'start':(31, 10), 'end':(31, 23), 'text':'following normalization for EGFR expression levels is shown in Figure ( bottom ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(32, 0), 'end':(32, 6), 'text':'These results are consistent with our finding'}, {'label':'joint', 'direction':'None', 'children':[{'start':(32, 7), 'end':(32, 24), 'text':'that p85 binding to Gab1 does not influence the recruitment of Shp2 to the Gab1 signaling complex ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 25), 'end':(32, 30), 'text':'and are inconsistent with the conclusion'}, {'start':(32, 31), 'end':(32, 43), 'text':'that Gab1 mediates a PI-3 kinase dependent recruitment of Shp2 [ ] .'}]}]}]}, {'start':(33, 0), 'end':(33, 26), 'text':'We next explored the role of Gab1 in EGF induced activation of the PI-3 kinase and Akt cell survival pathway utilizing the Gab1 F446/472/589 expressing cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 4), 'text':'We first assayed the Gab1'}, {'start':(34, 5), 'end':(34, 15), 'text':'associated PI-3 kinase activity directly through a PI-3 kinase assay .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 4), 'text':'As shown in Figure ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 5), 'end':(35, 9), 'text':'immunoprecipitation of wild type Gab1'}, {'start':(35, 10), 'end':(35, 19), 'text':'following EGF treatment brings down associated PI-3 kinase activity .'}]}]}, {'start':(36, 0), 'end':(36, 22), 'text':'However immunoprecipitation of Gab1 F446/472/589 is not associated with significant levels of PI-3 kinase in the presence or absence of EGF stimulation .'}]}, {'label':'summary', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(37, 0), 'end':(37, 15), 'text':'In order to assay the effects of EGF stimulation on signaling downstream of PI-3 kinase ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(37, 16), 'end':(37, 19), 'text':'Gab1 -/ - MEFs'}, {'label':'joint', 'direction':'None', 'children':[{'start':(37, 20), 'end':(37, 36), 'text':'expressing no Gab1 , wild type Gab1 or Gab1 F446/472/589 were treated with EGF over varying times'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 37), 'end':(37, 43), 'text':'and cell lysates were immunoblotted for serine'}, {'start':(37, 44), 'end':(37, 46), 'text':'phosphorylated Akt .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 17), 'text':'Mutation of the p85 binding sites on Gab1 essentially eliminated all EGF induced Akt activation relative to cells'}, {'start':(38, 18), 'end':(38, 22), 'text':'expressing wild type Gab1 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 15), 'text':'The binding of p85 is absolutely required for Gab1 mediated activation of PI-3 kinase and Akt'}, {'start':(39, 16), 'end':(39, 21), 'text':'following EGF treatment [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(40, 0), 'end':(40, 3), 'text':'Previous work has indicated'}, {'start':(40, 4), 'end':(40, 29), 'text':'that treatment of cells with PI-3 kinase inhibitors reduces levels of EGF induced complex formation between Gab1 and the protein tyrosine phosphatase Shp2 [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 14), 'text':'This finding suggests a role for Gab1 in the PI-3 kinase dependent recruitment of Shp2'}, {'start':(41, 15), 'end':(41, 18), 'text':'following EGF stimulation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 4), 'text':'We have examined the possibility'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(42, 5), 'end':(42, 14), 'text':'that mutation of the p85 binding sites on Gab1 ,'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(42, 15), 'end':(42, 26), 'text':'which prevents PI-3 kinase activation , altered EGF induced recruitment of Shp2'}, {'start':(42, 27), 'end':(42, 38), 'text':'as compared to the recruitment of Shp2 by wild type Gab1 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 17), 'text':'For this purpose , lysates from unstimulated or EGF stimulated cells were subjected to immunoprecipitation with anti-Gab1 antibodies'}, {'start':(43, 18), 'end':(43, 23), 'text':'following immunoblotting with anti-Shp2 antibodies .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 1), 'text':'The experiment'}, {'start':(44, 2), 'end':(44, 5), 'text':'presented in Fig shows'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 6), 'end':(44, 22), 'text':'that mutation of the p85 binding sites on Gab1 did not affect recruitment of Shp2 by Gab1'}, {'start':(44, 23), 'end':(44, 26), 'text':'following EGF stimulation .'}]}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(45, 0), 'end':(45, 7), 'text':'As has been previously observed [ ] ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 8), 'end':(45, 24), 'text':'we noted a low level of basal association between Shp2 and both Gab1 and Gab1 F446/472/589 ,'}, {'start':(45, 25), 'end':(45, 41), 'text':'which may be due to incomplete growth factor starvation prior to EGF stimulation in these experiments .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(46, 0), 'end':(46, 9), 'text':'Expression of Gab1 mutant protein deficient in Shp2 binding rescues'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 10), 'end':(46, 21), 'text':'EGF induced PI-3 kinase and Akt activation in Gab1 -/ - MEFs'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 13), 'text':'To assess the role of the protein tyrosine phosphatase Shp2 in Gab1 mediated signaling'}, {'start':(47, 14), 'end':(47, 22), 'text':'induced by EGF , two Gab1 mutants were generated'}]}, {'start':(47, 23), 'end':(47, 32), 'text':'and expressed in pools of Gab1 -/ - MEFs .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 18), 'text':'The first contained tyrosine to phenylalanine point mutations at the two binding sites for the Shp2 protein tyrosine phosphatase'}, {'start':(48, 19), 'end':(48, 23), 'text':'( Y627F and Y659F )'}]}, {'start':(48, 24), 'end':(48, 48), 'text':'( designated Gab1 F627 and 659 ) and the second contained mutations at the Shp2 binding sites as well as at the three PI-3 kinase'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 49), 'end':(48, 52), 'text':'binding sites described above'}, {'start':(48, 53), 'end':(48, 62), 'text':'( designated Gab1 F446/472/589 / 627 and 659 ) .'}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 9), 'text':'We first assayed the ability of the mutant Gab1 proteins'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 10), 'end':(49, 12), 'text':'to become tyrosine'}, {'start':(49, 13), 'end':(49, 18), 'text':'phosphorylated in response to EGF .'}]}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(50, 0), 'end':(50, 3), 'text':'As shown in Figure'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(50, 4), 'end':(50, 23), 'text':'( top panel ) both wild type Gab1 protein and the Gab1 F627 and 659 protein readily undergo tyrosine phosphorylation'}, {'start':(50, 24), 'end':(50, 28), 'text':'when stimulated with EGF .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(51, 0), 'end':(51, 3), 'text':'Quantitation following densitometry indicates'}, {'start':(51, 4), 'end':(51, 20), 'text':'that Gab1 F627 and 659 is reproducibly tyrosine phosphorylated to levels approximately 1.5-fold higher than Gab1 .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(52, 0), 'end':(52, 2), 'text':'This result suggests'}, {'label':'joint', 'direction':'None', 'children':[{'start':(52, 3), 'end':(52, 11), 'text':'that Gab1 may be a substrate of Shp2 ,'}, {'start':(52, 12), 'end':(52, 24), 'text':'and that blocking Shp2 binding thereby increases EGF induced Gab1 tyrosine phosphorylation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 2), 'text':'The Gab1 F446/472/589'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 3), 'end':(53, 14), 'text':'/ 627 and 659 mutant reproducibly displayed lower levels of tyrosine phosphorylation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 15), 'end':(53, 18), 'text':'following treatment with EGF'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(53, 19), 'end':(53, 19), 'text':'suggesting'}, {'start':(53, 20), 'end':(53, 31), 'text':'that these five tyrosines are the main phosphorylation sites on Gab1 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 6), 'text':'Immunoprecipitation of cell lysates with anti-Gab1 antibodies'}, {'start':(54, 7), 'end':(54, 7), 'text':'followed'}]}, {'start':(54, 8), 'end':(54, 13), 'text':'by immunoblotting with anti-Shp2 antibodies demonstrates'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 14), 'end':(54, 22), 'text':'that wild type Gab1 forms a complex with Shp2'}, {'start':(54, 23), 'end':(54, 26), 'text':'following EGF treatment ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 27), 'end':(54, 41), 'text':'while the Gab1 F627 and 659 mutant proteins fail to show an association with Shp2'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(54, 42), 'end':(54, 43), 'text':'thus confirming'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 44), 'end':(54, 54), 'text':'that phosphorylation of Tyr627 and 659 is required for Shp2 binding'}, {'start':(54, 55), 'end':(54, 58), 'text':'( Fig ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 2), 'text':'The basal interaction'}, {'start':(55, 3), 'end':(55, 24), 'text':'we observed between Gab1 and Shp2 in the absence of EGF stimulation is absent in the Gab1 F627 and 659 mutant ,'}]}, {'start':(55, 25), 'end':(55, 33), 'text':'even following prolonged exposures of the western blot .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 13), 'text':'We did not detect a change in the tyrosine phosphorylation of EGFR in cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 14), 'end':(56, 16), 'text':'expressing Gab1 proteins'}, {'start':(56, 17), 'end':(56, 24), 'text':'that are deficient in recruitment of Shp2 .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 0), 'end':(57, 1), 'text':'The experiment'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 2), 'end':(57, 6), 'text':'presented in Fig shows cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 7), 'end':(57, 17), 'text':'stimulated with EGF over varying periods of time and cell extracts'}, {'start':(57, 18), 'end':(57, 25), 'text':'assayed for levels of EGFR tyrosine autophosphorylation .'}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(58, 0), 'end':(58, 5), 'text':'As has been previously reported ,'}, {'start':(58, 6), 'end':(58, 23), 'text':'recruitment of Shp2 by Gab1 does not alter the magnitude or kinetics of tyrosine autophosphorylation of EGFR .'}]}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 6), 'text':'Levels of EGFR autophosphorylation are represented linearly'}, {'start':(59, 7), 'end':(59, 17), 'text':'following quantitation by densitometry and normalization for protein expression levels .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(60, 0), 'end':(60, 23), 'text':'Previous work with Shp2 -/ - cells demonstrated an elevated and sustained activation of PI-3 kinase and Akt in response to EGF treatment ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(60, 24), 'end':(60, 27), 'text':'and it was proposed'}, {'label':'joint', 'direction':'None', 'children':[{'start':(60, 28), 'end':(60, 36), 'text':'that Shp2 may act to dephosphorylate Gab1 at one'}, {'start':(60, 37), 'end':(60, 46), 'text':'or both of the p85 binding sites [ ] .'}]}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 8), 'text':'We utilized the Gab1 proteins deficient in Shp2 binding'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 9), 'end':(61, 20), 'text':'to assay more directly the role of the Shp2 and Gab1 complex'}, {'start':(61, 21), 'end':(61, 34), 'text':'in mediating activation of PI-3 kinase and Akt in response to EGF stimulation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(62, 0), 'end':(62, 4), 'text':'As shown in Figure ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 5), 'end':(62, 25), 'text':'immunoprecipitation of Gab1 F627 and 659 brings down 1.6-fold higher basal levels of PI-3 kinase activity relative to wild type Gab1'}, {'start':(62, 26), 'end':(62, 31), 'text':'as assayed by PIP3 production .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 12), 'text':'Importantly , Gab1 mutants defective for Shp2 binding show approximately 2-fold higher Gab1'}, {'start':(63, 13), 'end':(63, 22), 'text':'associated PI-3 kinase activity in response to EGF treatment .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(64, 0), 'end':(64, 8), 'text':'Consistent with these findings , previous studies have demonstrated'}, {'start':(64, 9), 'end':(64, 22), 'text':'that cells transiently over-expressing Gab1 F627 and 659 bound more p85 [ ] .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(65, 0), 'end':(65, 9), 'text':'In both Gab1 and Gab1 F627 and 659 expressing cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 10), 'end':(65, 11), 'text':'the Gab1'}, {'start':(65, 12), 'end':(65, 21), 'text':'associated PI-3 kinase activity is augmented by EGF treatment .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(66, 0), 'end':(66, 2), 'text':'As expected ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(66, 3), 'end':(66, 12), 'text':'the additional mutation of the p85 binding sites eliminates Gab1'}, {'start':(66, 13), 'end':(66, 17), 'text':'associated PI-3 kinase activity .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(67, 0), 'end':(67, 15), 'text':'In order to assay the effects of EGF stimulation on signaling downstream of PI-3 kinase ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 16), 'end':(67, 20), 'text':'cells were treated with EGF'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(67, 21), 'end':(67, 33), 'text':'for varying periods of time and cell lysates were assayed for Akt activation'}, {'start':(67, 34), 'end':(67, 40), 'text':'by immunoblotting with P-Ser473 Akt antibodies .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(68, 0), 'end':(68, 2), 'text':'Interestingly , cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 3), 'end':(68, 21), 'text':'expressing the Gab1 F627 and 659 protein reproducibly showed activation of Akt with significantly sustained kinetics relative to cells'}, {'start':(68, 22), 'end':(68, 26), 'text':'expressing wild type Gab1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(69, 0), 'end':(69, 2), 'text':'As expected ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 3), 'end':(69, 26), 'text':'the additional mutation of the p85 binding sites ( Gab1 F446/472/589 / 627 and 659 ) limited Akt activation to levels similar to those'}, {'start':(69, 27), 'end':(69, 34), 'text':'observed in the Gab1 -/ - cells ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 35), 'end':(69, 43), 'text':'confirming the requirement for PI-3 kinase association with Gab1'}, {'start':(69, 44), 'end':(69, 53), 'text':'to induce EGF mediated activation of the Akt pathway .'}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(70, 0), 'end':(70, 2), 'text':'Taken together ,'}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(70, 3), 'end':(70, 24), 'text':'these results suggest a role for Shp2 in negatively regulating the EGF induced activation of the PI-3 kinase pathway via Gab1 ,'}, {'start':(70, 25), 'end':(70, 33), 'text':'possibly by dephosphorylating Gab1 at p85 binding sites .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 15), 'text':'Expression of ErbB3 in Gab1 -/ - MEFs enhances activation of the PI-3 kinase signaling pathway'}, {'start':(72, 0), 'end':(72, 16), 'text':'As described above , PI-3 kinase is recruited to the EGFR via the adaptor protein Gab1 .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 0), 'end':(73, 1), 'text':'The results'}, {'start':(73, 2), 'end':(73, 3), 'text':'presented here'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 4), 'end':(73, 4), 'text':'demonstrate'}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(73, 5), 'end':(73, 21), 'text':'that Gab1 is required for EGF induced activation of the PI-3 kinase pathway via the EGFR ,'}, {'start':(73, 22), 'end':(73, 39), 'text':'presumably because this receptor does not contain binding sites for the p85 regulatory subunit of PI-3 kinase .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(74, 0), 'end':(74, 18), 'text':'The catalytically inactive ErbB3 receptor , however , contains at least six binding sites for p85 [ ] ,'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(74, 19), 'end':(74, 30), 'text':'and thus may bypass the requirement for Gab1 in response to EGF'}, {'start':(74, 31), 'end':(74, 38), 'text':'by heterodimerizing with the catalytically active EGFR .'}]}]}, {'label':'condition', 'direction':'RightToLeft', 'children':[{'start':(75, 0), 'end':(75, 6), 'text':'In order to test this hypothesis ,'}, {'label':'joint', 'direction':'None', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(75, 7), 'end':(75, 10), 'text':'retroviral vectors were used'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 11), 'end':(75, 23), 'text':'to introduce either the Gab1 or ErbB3 genes into Gab1 -/ - MEFs'}, {'start':(75, 24), 'end':(75, 32), 'text':'that endogenously express the EGFR but not ErbB3 ,'}]}]}, {'start':(75, 33), 'end':(75, 44), 'text':'and pools of stable cell lines were selected for further analysis .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 0), 'end':(76, 8), 'text':'We first assayed the ability of the endogenous EGFR'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 9), 'end':(76, 11), 'text':'to be tyrosine'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 12), 'end':(76, 27), 'text':'autophosphorylated in response to EGF , as well as the ability of the exogenous ErbB3 receptor'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 28), 'end':(76, 30), 'text':'to be tyrosine'}, {'start':(76, 31), 'end':(76, 44), 'text':'phosphorylated in response to stimulation with either EGF or neuregulin ( NRG ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 0), 'end':(77, 1), 'text':'The experiment'}, {'start':(77, 2), 'end':(77, 5), 'text':'presented in Fig shows'}]}, {'label':'temporal', 'direction':'None', 'children':[{'start':(77, 6), 'end':(77, 18), 'text':'that all cell lines exhibit EGFR autophosphorylation in response to EGF treatment ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 19), 'end':(77, 21), 'text':'while only cells'}, {'start':(77, 22), 'end':(77, 37), 'text':'expressing the ectopically introduced ErbB3 protein show ErbB3 tyrosine phosphorylation in response to EGF stimulation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(78, 0), 'end':(78, 8), 'text':'Interestingly , ErbB3 reproducibly shows constitutive low-level tyrosine phosphorylation'}, {'start':(78, 9), 'end':(78, 19), 'text':'that is augmented only 1.3-fold in response to EGF treatment .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(79, 0), 'end':(79, 0), 'text':'Cells'}, {'start':(79, 1), 'end':(79, 12), 'text':'expressing ErbB3 show tyrosine phosphorylation in response to treatment with NRG .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(80, 0), 'end':(80, 11), 'text':'Expression of EGFR and ErbB3 in the appropriate cell lines was confirmed'}, {'start':(80, 12), 'end':(80, 23), 'text':'by immunoblotting with antibodies specific for EGFR and ErbB3 , respectively .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(81, 0), 'end':(81, 7), 'text':'The apparent decrease in EGFR expression in cells'}, {'start':(81, 8), 'end':(81, 11), 'text':'co-expressing EGFR and ErbB3'}]}, {'start':(81, 12), 'end':(81, 23), 'text':'following EGF treatment was not observed in repetitions of this experiment ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(81, 24), 'end':(81, 29), 'text':'and is likely due to a'}, {'start':(81, 30), 'end':(81, 32), 'text':'stripping anomaly .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(82, 0), 'end':(82, 3), 'text':'Additionally , we demonstrated'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(82, 4), 'end':(82, 8), 'text':'that Gab1 -/ - MEFs'}, {'start':(82, 9), 'end':(82, 23), 'text':'that express wild type Gab1 display Gab1 tyrosine phosphorylation in response to EGF treatment ,'}]}, {'start':(82, 24), 'end':(82, 39), 'text':'while Gab1 -/ - control cells or those expressing ErbB3 do not show Gab1 phosphorylation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(83, 0), 'end':(83, 7), 'text':'In order to test the ability of ErbB3'}, {'start':(83, 8), 'end':(83, 9), 'text':'to rescue'}]}, {'start':(83, 10), 'end':(83, 39), 'text':'the EGF induced activation of the PI-3 kinase and Akt signaling pathway in Gab1 -/ - MEFs , we first assayed these cells for EGF induced PI-3 kinase activity .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(84, 0), 'end':(84, 4), 'text':'Cells were either left unstimulated'}, {'label':'joint', 'direction':'None', 'children':[{'start':(84, 5), 'end':(84, 9), 'text':'or were stimulated with EGF'}, {'start':(84, 10), 'end':(84, 18), 'text':'and cell lysates were immunoprecipitated with anti-phosphotyrosine antibody .'}]}]}]}, {'start':(85, 0), 'end':(85, 13), 'text':'Phosphotyrosine associated PI-3 kinase activity was then assayed by analysis of PIP3 production .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(86, 0), 'end':(86, 4), 'text':'As shown in Figure ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(86, 5), 'end':(86, 6), 'text':'both cells'}, {'start':(86, 7), 'end':(86, 17), 'text':'expressing wild type Gab1 and ErbB3 show PI-3 kinase activity ,'}]}, {'start':(86, 18), 'end':(86, 25), 'text':'while Gab1 -/ - cells do not .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(87, 0), 'end':(87, 12), 'text':'Interestingly , EGF induces PI-3 kinase activity to a greater degree in cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(87, 13), 'end':(87, 17), 'text':'expressing Gab1 relative to cells'}, {'start':(87, 18), 'end':(87, 20), 'text':'expressing ErbB3 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(88, 0), 'end':(88, 15), 'text':'In order to assay the effects of EGF stimulation on signaling downstream of PI-3 kinase ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(88, 16), 'end':(88, 25), 'text':'cells were treated with EGF over varying periods of time'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(88, 26), 'end':(88, 32), 'text':'and assayed for the presence of Ser473'}, {'start':(88, 33), 'end':(88, 35), 'text':'phosphorylated Akt .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(89, 0), 'end':(89, 2), 'text':'Treatment of cells'}, {'start':(89, 3), 'end':(89, 17), 'text':'expressing either wild type Gab1 or ErbB3 with EGF induced rapid activation of Akt ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(89, 18), 'end':(89, 19), 'text':'although cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(89, 20), 'end':(89, 40), 'text':'expressing wild type Gab1 reproducibly displaed higher levels of phosphorylated Akt with significantly sustained kinetics relative to Gab1 -/ - cells'}, {'start':(89, 41), 'end':(89, 43), 'text':'expressing ErbB3 .'}]}]}]}]}]}, {'start':(90, 0), 'end':(90, 11), 'text':'Equal loading and expression levels of Akt were confirmed by immunoblotting .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(91, 0), 'end':(91, 0), 'text':'Cells'}, {'start':(91, 1), 'end':(91, 2), 'text':'expressing ErbB3'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(91, 3), 'end':(91, 20), 'text':'displayed activation of Akt in response to treatment with NRG at levels similar to or greater than that'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(91, 21), 'end':(91, 25), 'text':'seen in Gab1 expressing cells'}, {'start':(91, 26), 'end':(91, 38), 'text':'following EGF treatment , with activation reproducibly observed at longer time points .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(92, 0), 'end':(92, 13), 'text':'Again , equal loading and expression levels of Akt were confirmed by immunoblotting .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(93, 0), 'end':(93, 5), 'text':'The phosphorylation of AKT in cells'}, {'start':(93, 6), 'end':(93, 8), 'text':'expressing Gab1 ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(93, 9), 'end':(93, 12), 'text':'which shows modest enhancement'}, {'start':(93, 13), 'end':(93, 17), 'text':'following treatment with NRG ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(93, 18), 'end':(93, 24), 'text':'may be attributed to alternate signaling pathways'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(93, 25), 'end':(93, 26), 'text':'including those'}, {'start':(93, 27), 'end':(93, 32), 'text':'mediated by ErbB2 and ErbB4 .'}]}]}]}, {'start':(94, 0), 'end':(94, 10), 'text':'Involvement of these receptors was not explored in this study .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(95, 0), 'end':(95, 2), 'text':'Taken together ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(95, 3), 'end':(95, 5), 'text':'these results demonstrate'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(95, 6), 'end':(95, 10), 'text':'that ErbB3 can partially compensate'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(95, 11), 'end':(95, 16), 'text':'for Gab1 deficiency in EGF induced'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(95, 17), 'end':(95, 26), 'text':'activation of the PI-3 kinase and Akt signaling pathway ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(95, 27), 'end':(95, 42), 'text':'although Gab1 mediated activation appears to be more robust , and likely represents the primary mechanism'}, {'start':(95, 43), 'end':(95, 51), 'text':'by which EGF stimulates PI-3 kinase and Akt .'}]}]}]}]}]}]}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(96, 0), 'end':(96, 13), 'text':'While ErbB3 is relatively ineffective at mediating EGF stimulation of PI-3 kinase activation ,'}, {'start':(96, 14), 'end':(96, 28), 'text':'it is an efficient mediator of PI-3 kinase stimulation in response to NRG stimulation .'}]}]}]}]}]}]}]}]}, {'start':(97, 0), 'end':(97, 23), 'text':'Thus , EGF and NRG can stimulate PI-3 kinase activation in normal and transfected cells by means of Gab1 and ErbB3 , respectively .'}]}
187	193	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Authors \' contributions'}, {'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 6), 'text':'BL carried on the initial biochemical experiments'}, {'start':(1, 7), 'end':(1, 11), 'text':'before leaving the laboratory .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 3), 'text':'DM continued this study'}, {'label':'joint', 'direction':'None', 'children':[{'start':(2, 4), 'end':(2, 15), 'text':'and carried out the biochemical studies , the PI-3 kinase assays ,'}, {'start':(2, 16), 'end':(2, 20), 'text':'and drafted the manuscript .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 7), 'text':'IL participated in the PI-3 kinase assays .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 1), 'text':'JS initiated'}, {'start':(4, 2), 'end':(4, 6), 'text':'and supervised the project .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 2), 'text':'All authors read'}, {'start':(5, 3), 'end':(5, 8), 'text':'and approved the final manuscript .'}]}]}
